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Abstract
Objective
To investigate neurologic outcome of patients with cardiac arrest with refractory status epi-
lepticus (RSE) treated with a standardized aggressive protocol with antiepileptic drugs and
anesthetics compared to patients with other EEG patterns.
Methods
In the prospective cohort study, 166 consecutive patients with cardiac arrest in coma were
stratified according to 4 independent EEG patterns (benign, RSE, generalized periodic dis-
charges [GPDs], malignant nonepileptiform) and multimodal prognostic indicators. Primary
outcomes were survival and cerebral performance category (CPC) at 6 months.
Results
RSE occurred in 36 patients (21.7%) and was treated with an aggressive standardized protocol
as long as multimodal prognostic indicators were not unfavorable. RSE started after 3 ± 2.3 days
after cardiac arrest and lasted 4.7 ± 4.3 days. A benign EEG pattern was recorded in 76 patients
(45.8%); a periodic pattern (GPDs) was seen in 13 patients (7.8%); and a malignant non-
epileptiform EEG pattern was recorded in 41 patients (24.7%). The 4 EEG patterns were highly
associated with different prognostic indicators (low-flow time, clinical motor seizures, N20
responses, neuron-specific enolase, neuroimaging). Survival and good neurologic outcome
(CPC 1 or 2) at 6 months were 72.4% and 71.1% for benign EEG pattern, 54.3% and 44.4% for
RSE, 15.4% and 0% for GPDs, and 2.4% and 0% for malignant nonepileptiform EEG pattern,
respectively.
Conclusions
Aggressive and prolonged treatment of RSE may be justified in patients with cardiac arrest with
favorable multimodal prognostic indicators.
From the Epilepsy Center (S.B., C.Z., D.C. A.S., G.P., G.B., C.F.), Department of Neurology, and Department of Intensive Care (A.C., E.S., A.G., G.F., L.A.), San Gerardo Hospital ASST
Monza, University of Milano Bicocca, Monza; Department of Neuroscience (E.B., E.B.), IRCCS Mario Negri Institute for Pharmacological Research; and Department of Anesthesia
(A.P.), Critical Care and Emergency, IRCCS Ospedale Maggiore Policlinico, Milano, Italy.
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Copyright © 2018 American Academy of Neurology 1
Copyright ª 2018 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
 Published Ahead of Print on October 31, 2018 as 10.1212/WNL.0000000000006615
Prognostication of neurologic outcome in patients in coma
after cardiac arrest requires a multimodal diagnostic approach
to assess the severity of postanoxic encephalopathy, which
includes clinical examination, EEG pattern, somatosensory
evoked potentials, neuron-specific enolase (NSE), and
neuroimaging.1
Refractory status epilepticus (RSE) has been reported in up to
30% of comatose patients after cardiac arrest with continuous
EEG (cEEG),2–4 is frequently associated with clinical motor
seizures (myoclonic, clonic, or tonic-clonic),5 and is typically
resistant to moderate-intensity, unstandardized treatment.6
The standardized American Clinical Neurophysiology Society
(ACNS) terminology of critical care EEG7 and the Salzburg
criteria for nonconvulsive status epilepticus (NCSE)8,9 allow
a clear distinction of 2 EEG patterns, which are frequently
reported under the same term “status epilepticus.” Sharply
contoured generalized periodic discharges (GPDs; GPDs+,
previously called generalized periodic epileptic discharges)
have consistently been reported as a highly malignant pattern
associated with a poor neurologic prognosis.10 RSE without
periodic discharges has also been associated with poor prog-
nosis,11 but a subset of these patients might achieve a good
functional recovery.12,13
Both the intensity and duration of treatment of RSE in
postanoxic patients are controversial and raise ethical issues
of therapeutic obstinacy vs premature withdrawal of life
support.14,15
In the present study, we investigated survival and long-term
neurologic outcome in consecutive postanoxic patients with
RSE without periodic discharges treated with an aggressive
standardized protocol compared to patients with a benign EEG
pattern, a nonepileptiform malignant EEG pattern, and GPDs.
Methods
Study protocol approvals, registrations, and
patient consents
This prospective cohort study explored survival and long-term
neurologic outcome of postanoxic patients with RSE after ag-
gressive standardized treatment. This study was approved by
the Ethics Committee of San Gerardo Hospital, Monza, Italy.
Consecutive patients in coma after cardiac arrest admitted
between January 2011 and May 2016 in the hospital’s cardiac
intensive care unit (ICU) were included in the study.
To be included in the cohort, patients had to be in a coma for
>24 hours after cardiac arrest. Patients who regained con-
sciousness or died <24 hours after cardiac arrest were excluded.
Data collection was performed by review of medical records
for demographics and clinical data, including clinical motor
seizures, brainstem reflexes, NSE, somatosensory evoked
potentials, and neuroimaging. EEG patterns within the first 5
days from cardiac arrest were independently reviewed and
categorized by 3 neurophysiologists (see below). Neurologic
outcome was assessed at 6 months after cardiac arrest by
telephone contact (see below).
Aggressive standardized treatment of
postanoxic status epilepticus
Patients were treated according to the local institutional
protocol for reducing brain damage after cardiac arrest (figure
1). This includes targeted temperature management at 34°C
for 24 hours, simplified 4-channel cEEG monitoring applied
within 24 hours from cardiac arrest, and on-call neurologic
consultations with an epilepsy specialist. Standard 18-channel
EEG recording was performed twice in the first 5 days or more
frequently if clinically indicated, in addition to cEEG.
A multimodal prognostic approach was applied in all cases;
i.e., an unfavorable profile was considered whenmost indicators
converged indicating a poor prognosis, while a not unfavorable
(i.e., potentially favorable) profile was considered when most
indicators converged against a poor prognosis. Brainstem
reflexes (pupillary, corneal) were performed within 24 hours
and if bilaterally absent were considered indicators of poor
prognosis. NSE levels were performed at 48 hours, and we
adopted the cutoff of >68 ng/mL as an indicator of poor
prognosis.16 Median nerve somatosensory evoked potentials
were performed at 72 hours if patients remained in coma, and if
bilaterally absent, they were considered indicators of poor
prognosis. Neuroimaging (CT or MRI) was performed if
clinically indicated and feasible. If moderate to severe anoxic
brain injury was present (see below), it was considered an
indicator of poor prognosis.
Early identification of prognostic EEG patterns (see below) was
performed by on-call epilepsy specialists within the first 5 days
after cardiac arrest, with multiple consultations as needed. If
status epilepticus was detected by cEEG during hypothermia or
rewarming, IV benzodiazepines and IV valproate, levetiracetam,
and/or phenytoin were administered, followed within 60
minutes by a first anesthetic-induced coma with propofol and/
or midazolam for 48 hours if epileptic activity was refractory to
Glossary
ACNS = American Clinical Neurophysiology Society; AED = antiepileptic drug; cEEG = continuous EEG; CI = confidence
interval; CPC = cerebral performance category; GPD = generalized periodic discharge; ICU = intensive care unit; NCSE =
nonconvulsive status epilepticus; NSE = neuron-specific enolase; OR = odds ratio; RSE = refractory status epilepticus;
TELSTAR = Treatment of Electroencephalographic Status Epilepticus After Cardiopulmonary Resuscitation.
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treatment, guided by cEEG monitoring. Other antiepileptic
drugs (AEDs; lacosamide, topiramate, perampanel) and/or
cycles of anesthetics-induced coma (propofol, midazolam,
thiopental, ketamine) were administered if needed, guided by
cEEG and available prognostic indicators (figure 1 provides
details). Our protocol for aggressive standardized treatment of
postanoxic status epilepticus was developed from the results of
previous expert opinions on this topic.17,18
Study definitions
Status epilepticus was defined according to the International
League Against Epilepsy classification.19 In accordance with
the Salzburg EEG criteria,8 a frequency of epileptiform dis-
charges (sharp waves and spikes) >2.5 Hz was applied for the
diagnosis of NCSE. A minimum duration of 30 minutes of
electrographic seizure activity was used for the diagnosis of an
episode of NCSE. No patients included in this study had
previous epileptic encephalopathy.
Status epilepticus was defined as refractory (RSE) after
failure of benzodiazepines and a first IV AED and super-
refractory after failure of a first cycle (≥48 hours) of
anesthetics-induced burst-suppression pattern (burst sup-
pression rate >70%).
Figure 1 Standardized protocol for treatment of hypoxic-ischemic encephalopathy in the intensive care unit
AED = antiepileptic drug; BSR = burst suppression rate (percent of time thewaveform is isoelectric over the previous 60 seconds); cEEG = continuous EEG; NSE
= neuron-specific enolase; RSE = refractory status epilepticus. *Antiepileptic drugs. First-line: valproate 30 mg/kg IV bolus + 1.5 mg/kg IV maintenance;
levetiracetam 40mg/kg IV bolus + 2 to 5mg/kg IV maintenance; phenytoin (if contraindication to valproate/levetiracetam and absent cardiac risks) 20 mg/kg
IV bolus + 5mg/kg oralmaintenance (frequent plasma levels to adjust dose). Second-line: lacosamide 400mg IV bolus + 400mg/d IVmaintenance; topiramate
300 to 500mgoral loading + 200 to 400mg/d oralmaintenance; perampanel 6 to 12mgoral loading + 4 to 12mg/d oralmaintenance. **Anesthetics. First-line:
propofol 1 to 2mg/kg IV bolus + 2 to 6mg/kg/h IVmaintenance, target burst suppression guided by cEEG (60%–70%BSR) ±midazolam. Second-line: thiopental
5–15mg/kg IV bolus + 0.5 to 10mg/kg/h IVmaintenance, target burst suppression guided by cEEG (60%–70%BSR); ketamine 1.5 to 3mg/kg IV bolus + 1–5mg/
kg/h IV maintenance, target typical ketamine pattern, no epileptiform discharges ± midazolam.
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Motor seizures were defined as any observable myoclonic,
clonic, or tonic-clonic manifestation occurring during the
entire stay in the ICU.
Status myoclonus was defined as continuous and generalized
myoclonic jerks with a duration of >30 minutes1 within the
first 5 days after cardiac arrest.
GPDs were defined as sharply contoured, sharp or spiky
discharges showing a periodic pattern7 with a frequency <2.5
Hz. A minimum duration of 30 minutes of continuous peri-
odic discharges was used for the diagnosis of an episode of
GPDs. Periodic discharges with a frequency >2.5 Hz were
considered status epilepticus.
EEG background activity was categorized as continuous
(<10% periods of attenuation or suppression) or discontin-
uous (>10% periods of attenuation or suppression, including
spontaneous burst suppression and suppression).
EEG background reactivity was defined as any response eli-
cited by auditory or noxious stimuli, excluding stimulus-
induced rhythmic periodic or ictal discharges.
MRI evidence of anoxic brain injury was dichotomized as mild
or moderate to severe according to diffusion-weighted imag-
ing or fluid-attenuated inversion recovery abnormalities in the
cortical gray matter and deep basal ganglia.20
CT evidence of anoxic brain injury was dichotomized as mild
or moderate to severe according to the ratio of gray matter to
white matter and diffuse cerebral edema.21
Prognostic EEG pattern
Fourmutually exclusive EEG patterns within the first 5 days after
cardiac arrest were defined as follows: (1) benign EEG pattern:
continuous or reactive (or both) EEG background activity at any
time point, with no episodes of status epilepticus or GPDs; (2)
RSE pattern: ≥1 episodes of RSE at any time point, with no
episodes of GPDs <2.5 Hz at any time, independently of EEG
background activity; (3) GPD pattern: ≥1 episodes of GPDs
<2.5 Hz at any time point, independently of EEG background
activity or RSE; and (4)malignant nonepileptiformEEGpattern:
consistently discontinuous and unreactive EEG background ac-
tivity, with no episodes of status epilepticus or GPDs at any time.
Examples of the 4 prognostic EEG patterns are illustrated in
figure 2. Three neurophysiologists independently reviewed
the EEGs of different patients and categorized them in the 4
EEG patterns. The interrater agreement was tested with the
Fleiss κ on 25 randomly selected EEG recordings from the
same patients (15% of the study population).
Sample size
Assuming that mortality in patients meeting the inclusion
criteria and without RSE is 50%, with 206 patients enrolled,
the study had sufficient statistical power (80%) to detect
Figure 2 Prognostic EEG patterns in post–cardiac arrest patients
Representative epochs from 4-channel continuous EEG monitoring of patients with (A) benign EEG pattern, (B) refractory status epilepticus pattern, (C)
generalized periodic discharge pattern, and (D) malignant nonepileptiform EEG pattern.
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a 20% absolute difference between patients with and without
RSE with a 5% level of significance (p = 0.05).
Study outcomes
Primary outcomes were survival and neurologic disability,
assessed with the cerebral performance category (CPC), at 6
months after cardiac arrest.22 All patients or caregivers were
contacted by phone call; no patient was lost to follow-up.
CPC ranges from 1 to 5, with 1 representing intact function
and 5 representing brain death. CPC was dichotomized as
follows: patients with a CPC of 1 or 2 were classified as having
good neurologic outcome, and patients with a CPC of ≥3
were classified as having poor neurologic outcome.
Statistical analysis
Descriptive statistics were performed in the study population for
the main demographic and clinical variables. Data are reported as
frequencies and percentages for categorical variables or as
medians and interquartile ranges for continuous variables. Se-
lected prognostic indicators (clinical motor seizures, low-flow
time, N20, NSE, neuroimaging) were described separately for
each EEG pattern and compared by use of the χ2 or the
Wilcoxon-Mann-Whitney test. Clinical characteristics of RSE
(onset, duration, response to treatment) were described with
means, SDs, ranges, frequencies, percentages, and cumulative
incidence functions. The effect of demographic and clinical var-
iables on study outcomes was evaluated with univariable logistic
regression models. Results are reported as odds ratios (ORs)
with 95% confidence intervals (95% CIs). The significance level
was set at 0.05. Statistical analyses were performed with the SAS
statistical package (version 9.4; SAS Institute, Cary, NC).
Data availability
Anonymized data will be shared on request from any qualified
investigator.
Results
Study population
The initial cohort consisted of 206 consecutive patients with
cardiac arrest; 40 patients were excluded because they died
within the first 24 hours and were not EEG monitored. All
remaining 166 patients survived the first 24 hours, had cEEG
monitoring, and were included in the analysis.
Therapeutic hypothermia (34°C) for 24 hours, followed by
gradual rewarming over the next 12 hours, was applied in 148
patients (89.1%). Demographic and clinical characteristics of
the study population are shown in table 1. Median age was 61
years (interquartile range 51–71 years). Most patients had
preserved brainstem reflexes (pupillary 84.1%, corneal 70.1%)
and bilaterally present cortical N20 responses (82.5%). Early
brain imaging withMRI or CT (within 7 days) was performed
in 87 patients (52.4%) and showed moderate to severe anoxic
brain injury in 33 patients (37.9%).
Prognostic EEG patterns
cEEG monitoring was used to categorize patients in the 4 dis-
tinct, mutually exclusive EEG patterns within the first 5 days of
recording: 76 patients (45.8%) had a benign EEG pattern; 36
patients (21.7%) hadRSE; 13 patients (7.8%) hadGPDs; and 41
patients (24.7%) had a malignant nonepileptiform EEG pattern
(table 2). Interrater agreement was very high (κ = 0.92).
Table 1 Clinical characteristics of the study population
Unit Median or n (%) IQR
Age Years 61.0 51.0–71.0
Days in ICU Days 7.5 4.0–15.0
Sex Male, n (%)/female, n (%) 120 (72.7)/46 (27.7)
No-flow time Minutes 1.0 1.0–7.5
Low-flow time Minutes 28.0 14.5–53.0
Out-of-hospital cardiac arrest n (%) 112 (67.5)
ECMO n (%) 84 (50.6)
Hypothermia n (%) 148 (89.1)
Pupillary reflexa Bilaterally present, n (%) 127 (84.1)
Corneal reflexa Bilaterally present, n (%) 103 (70.19)
NSE μg/L 48.0 31.6–98.7
Cortical N20 responseb Bilaterally absent, n (%) 20 (17.5)
MRI or CT (within 7 d) Performed in n (%) 87 (52.4)
Abbreviations: ECMO = extracorporeal membrane oxygenation; ICU = intensive care unit; IQR = interquartile range; NSE = neuron-specific enolase.
a Missing data in 9.0% for pupillary reflex and 11.4% for corneal reflex.
b Missing data in 31.3% for cortical N20 responses (patients either awakened or died before performingmedian nerve somatosensory evoked potentials at 72
hours).
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The 4 EEG patterns were highly associated with different
prognostic indicators (clinical motor seizures p < 0.0001, low-
flow time p < 0.0001, N20 p < 0.0001, NSE p < 0.0001,
neuroimaging p = 0.0003). RSE displayed similarities with the
benign EEG pattern, while GPDs displayed similarities with
the malignant nonepileptiform EEG pattern for low-flow time
(p < 0.0001), N20 (p < 0.0001), NSE (p < 0.0001), and
neuroimaging (p < 0.0001) but not for clinical motor seizures
(p = 0.8673), as shown in table 2.
Characteristics and treatment of RSE
Status epilepticus occurred in 43 (25.9%) patients and met
the criteria for RSE pattern in 36 (21.7%) patients while in 7
(4.2%) patients evolved from an RSE to GPDs within the first
5 days. These patients were considered to have GPDs, to-
gether with 6 other (3.6%) patients who exhibited GPDs
exclusively.
Clinical motor seizures (myoclonic, clonic, or tonic-clonic)
during the ICU stay were more prevalent in patients with
GPDs (61.5%) compared to those with RSE (44.4%), as
shown in table 2. Status myoclonus was the most common
type of clinical seizure manifestation in GPDs (62.5%), while
it was infrequent in RSE (18.7%). All patients with status
myoclonus had poor neurologic outcome.
Timing of RSE is shown in figure 3. The mean onset of RSE
was 3 ± 2.3 days after cardiac arrest. The mean duration of
Table 2 EEG patterns, clinical seizures, and selected prognostic indicators
EEG pattern (day
0–5) n (%)
Clinical motor
seizures, n (% of
pattern)
Status myoclonus,
n (% of motor
seizures)
Low-flow
time
(median),
min
NSE
(median), μg/
L
Absenta N20,
n (% of
pattern)
MRI-CT anoxic
injury,b n (% of
subset)
Benign EEG
pattern
76
(45.8)
6 (7.8) 0 (0) 20 36 3 (4.5) 7 (19.4)
RSE pattern 36
(21.7)
16 (44.4) 3 (18.7) 26 47 4 (16.7) 4 (22.2)
GPD pattern 13
(7.8)
8 (61.5) 5 (62.5) 40 99 6 (54.6) 5 (62.5)
Malignant
nonepileptiform
EEG pattern
41
(24.7)
4 (9.8) 3 (75.0) 56 248 7 (58.3) 17 (68.5)
Total 166
(100)
34 (20.5) 11 (32.3) 28 48 20 33 (37.9)
Abbreviation: GPD = generalized periodic discharge; NSE = neuron-specific enolase; RSE = refractory status epilepticus.
a Bilaterally absent cortical N20 responses missing data in 31.3% for cortical N20 responses (patients either awakened or died before performing somato-
sensory median nerve evoked potentials at 72 hours).
b Moderate to severe degree of anoxic brain injury based on MRI or CT imaging <7 days (performed in a subset of 87 patients).
Figure 3 Time course of RSE in post–cardiac arrest patients
Cumulative incidence with 95% confidence interval (CI) is shown for (A) onset and (B) duration of refractory status epilepticus (RSE).
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RSE was 4.7 ± 4.3 days after onset. Treatment was successful
in terminating RSE in 35 (81.4%) patients, while 8 (18.6%)
patients died during RSE.
Status epilepticus was refractory in all cases and super-
refractory in 21 (58.3%) cases, requiring treatment with
anesthetics and multiple AEDs. The mean number of AEDs
used was 3.2 (range 1–7). The mean number of anesthetic
cycles was 2.4 (range 1–5), and the mean number of days of
anesthesia was 4.8 (range 0.8–14.2). A total of 85 anesthetic
cycles were used for treating RSE in the study population:
a combination of propofol and midazolam was used in 72.3%
of cycles, while thiopental was used in 21.2% and ketamine
in 4.7%.
Long-term neurologic outcome and survival
Considering the entire cohort, survival was achieved in 77
(46.4%) patients and good neurologic outcome (CPC 1–2)
in 70 (42.2%) patients at 6 months (table 3). The EEG
pattern in the first 5 days after cardiac arrest was highly
associated with both survival (p = 0.0001) and neurologic
outcome (p < 0.0001).
Table 3 Effect of EEG patterns on neurologic outcome and survival at 6 months
EEG pattern (day 0–5) Survival, n (%) OR (95% CI) p Value CPC 1–2, n (%) OR (95% CI) p Value
Benign EEG pattern 55/76 (72.4) 1.00 (referent) 54/76 (71.0) 1.00 (referent)
RSE pattern 19/36 (52.8) 0.43 (0.19–0.97) 0.0431 16/36 (44.4) 0.33 (0.13–0.80) 0.0127
GPD pattern 2/13 (15.4) 0.07 (0.01–0.34) 0.0010 0/13 (0.0) 0.02 (0.00–0.12) <0.0001
Malignant nonepileptiform EEG pattern 1/41 (2.4) 0.01 (0.00–0.07) <0.0001 0/41 (0.0) 0.01 (0.00–0.04) <0.0001
Main effect of EEG patterns 0.0001 <0.0001
Abbreviations: CI = confidence interval; CPC = cerebral performance category; GPD = generalized periodic discharge; OR = odds ratio.
Table 4 Effect of selected prognostic indicators on good neurologic outcome (top) and survival (bottom) in the study
population
CPC 1–2 CPC 3–5
OR 95% CI p Value
Median (IQR) or n (%) Median (IQR) or n (%)
Low flow (min) for 1-min increase 10 10–30 40 22–61 0.96 0.94–0.97 <0.0001
Absent pupillary reflexes 0 0 24 100 0.02 ne-0.11 <0.0001
Absent corneal reflexes 3 7 40 93 0.04 0.01–0.15 <0.0001
NSE for 1-unit increase 24 24–49 75 39–178 0.98 0.96–0.99 0.0006
Absent N20 responses 1 5.3 19 94.7 0.03 0.00–0.19 <0.0001
Neuroimaging (severe anoxic brain injury) 2 6.1 31 93.9 0.04 0.00–0.19 <0.0001
Absent EEG background reactivity 5 6.7 75 93.8 0.03 0.01–0.08 <0.0001
Survivors Nonsurvivors
OR 95% CI p Value
Median (IQR) or n (%) Median (IQR) or n (%)
Low flow (min) for 1-min increase 19 12–30 40 21–61 0.96 0.94–0.98 <0.0001
Absent pupillary reflexes 0 0 24 100 0.02 0.00–0.09 <0.0001
Absent corneal reflexes 6 13.6 38 86.4 0.07 0.03–0.19 <0.0001
NSE for 1-unit increase 38 24–54 75 38–228 0.98 0.97–0.99 0.0007
Absent N20 responses 3 15 17 85 0.08 0.02–0.28 <0.0001
Neuroimaging (severe anoxic brain injury) 5 15.2 28 84.8 0.10 0.03–0.29 <0.0001
Absent EEG background reactivity 11 13.8 69 86.2 0.06 0.03–0.29 <0.0001
Abbreviations: CI = confidence interval; CPC = cerebral performance category; IQR = interquartile range; NSE = neuron-specific enolase; OR = odds ratio.
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Patients with a benign EEG pattern had the highest chance of
both survival (72.4%) and good neurologic outcome (71.1%)
and were chosen as a reference to compare patients with other
EEG patterns. Patients with an RSE pattern had a moderate
reduction in survival (52.8%, OR 0.43, 95%CI 0.19–0.97) and
good neurologic outcome (44.4%, OR 0.33, 95% CI
0.13–0.80). Patients with GPDs has a dramatic reduction in
survival (15.4%, OR 0.07, 95% CI 0.01–0.34) and good
neurologic outcome (0%, OR 0.02, 95% CI 0.00–0.12). An
even more dramatic reduction was observed for patients with
malignant nonepileptiform EEG pattern for both survival
(2.4%, OR 0.01, 95% CI 0.00–0.07) and good neurologic
outcome (0%, OR 0.01, 95% CI 0.00–0.04).
The effects of selected prognostic indicators (low-flow time,
brainstem reflexes, N20, NSE, MRI, EEG background re-
activity) on survival and neurologic outcome in our pop-
ulation are shown in table 4.
Discussion
The intensity and duration of treatment of postanoxic RSE are
highly controversial issues.23,24 No evidence is currently
available on whether a more aggressive treatment would
substantially affect the final neurologic outcome in refractory
postanoxic status epilepticus.
Aggressive and prolonged treatment carries the risk of futil-
ity,25 while a low-intensity and short-lasting treatment carries
the risk of self-fulfilling prophecies, i.e., negative outcome
being the consequence of withdrawal of care due to (some-
times erroneous) prognostication of a negative outcome.26
This latter risk might be particularly high if prognostication
relies on a single negative indicator such as refractory epi-
leptiform EEG activity.
A multicenter randomized clinical trial (Treatment of Elec-
troencephalographic Status Epilepticus After Cardiopulmo-
nary Resuscitation [TELSTAR]) is ongoing to address this
issue.27 In the TELSTAR trial, patients are being randomized
to a stepwise, aggressive, EEG-guided treatment with AEDs
and anesthetics for 48 hours vs standard care without EEG
guidance.
In the present study, we reported survival and long-term
neurologic outcome of a prospective cohort of post–cardiac
arrest patients in coma for >24 hours who received a stan-
dardized aggressive treatment with AEDs and anesthetics if
RSE was detected by cEEG monitoring. Intensity and dura-
tion of treatment were guided not only by EEG but also by
multimodal prognostic indicators.
We adopted a strict definition of RSE, according to the In-
ternational League Against Epilepsy definition, ACNS termi-
nology, and Salzburg criteria. In particular, we made a clear
distinction between low-frequency (<2.5Hz) periodic discharges
(GPDs) and RSE without periodic discharges, which were
considered 2 mutually exclusive EEG patterns. In case of evo-
lution from RSE to GPDs, patients were considered to have
GPDs. Besides RSE and GPDs, we identified 2 other non-
epileptiform EEG patterns based on background activity and
reactivity that were called benign and malignant according to
previous studies.28,29 These 4 mutually exclusive EEG patterns
were easily and unequivocally identified in the first 5 days after
cardiac arrest with cEEG monitoring and allowed a prognostic
analysis.
Our results showed that patients with RSE represent a distinct
population in termof indicators of severity of anoxic brain injury
and may present a good neurologic prognosis in >40% with
a standardized, aggressive, and prolonged treatment.Our results
are remarkably different from recent observational studies
without aggressive standardized treatment, which reported
<10% of good neurologic outcome in postanoxic patients with
RSE defined according to the ACNS terminology.30,31
Compared to patients with GPDs, patients with RSE dis-
played lower low-flow time andNSE levels and were less likely
to show clinical motor seizures, absent N20 responses, and
severe anoxic brain injury on neuroimaging. The 4 EEG
patterns delineate a range of severity of anoxic brain injury and
were strongly associated with long-term survival and neuro-
logic prognosis, with patients with RSE appearing more
similar to patients with a benign EEG pattern and patients
with GPDs appearing more similar to patients with a malig-
nant nonepileptiform EEG pattern.
We adopted a broad definition of clinical motor seizures,
including any observable myoclonic, clonic, or tonic-clonic
manifestation during the entire stay in the ICU. This defini-
tion has the advantage of taking into account the switching
between convulsive and NCSE over time (and with therapy).
Our findings indicate that the majority of RSE is non-
convulsive. Conversely, status myoclonus was far more
common in GPDs compared to RSE and was associated with
a negative outcome, as previously reported.1
Notably, no predefined limit of duration of treatment was
applied. Onset of RSE was variable with a mean of 3 days after
cardiac arrest, which could potentially be explained by the
combined effect of hypothermia and sedation in the first 24 to
48 hours. In >50% of cases, RSE lasted >72 hours, and in
≈30% of cases, RSE lasted >7 days. Aggressive treatment was
continued as long as needed in case of super-RSE if multi-
modal prognostic indicators were not unfavorable. Therefore,
treatment duration in our cohort is substantially longer than
48 hours, which is the predefined duration of treatment in the
TELSTAR trial. Our findings suggest that prolonged treat-
ment is necessary and beneficial in selected cases of post-
anoxic RSE and warn against early outcome prediction (and
early decisions of withdrawal of care) in case of RSE.
Conversely, the GPD pattern was regarded as an unfavorable
prognostic indicator on the basis of recent studies, which
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include GPDs within the highly malignant EEG patterns after
cardiac arrest.29 Therefore, we adopted a less aggressive
treatment in case of a GPD pattern, in most cases not ex-
ceeding 1 cycle of anesthetics-induced coma. Notably, no
patient included in this study received withdrawal of care,
intended as active reduction of respiratory support or vaso-
active drugs. Although we could not definitely exclude the risk
of self-fulfilling prophecies in patients with GPDs in our se-
ries, we think this is very unlikely in view of the current
evidence.
The study has strengths and limitations. The first strength is
the fairly large sample assessed and managed according to
a standardized prognostic and therapeutic program. A second
strength is the inclusion of patients from a single source,
which helps minimize the variability of measures intrinsic in
multicenter studies. A third strength is that no patient was lost
to follow-up.
The first limitation is selection bias because this series is from
a university hospital. Although we did our best to enroll
consecutive patients, we cannot exclude different outcomes
from patients enrolled in other centers and managed
according to different prognostic and therapeutic programs. A
second limitation is the use of hypothermia at 34°C for 24
hours for all patients included in this study, which may reduce
generalizability to patients routinely treated with normo-
thermia at 36°C. Patients were recruited from 2011 to 2016
and were treated according to the American Heart Associa-
tion guidelines (2010 and 2015), which recommend any
target core temperature between 32°C and 36°C, given the
continuing debate on this topic.32 A third limitation is the use
of a simplified EEG, instead of a full EEG, for continuous
monitoring. However, 18-channel EEG was performed at
least twice in the first 5 days to verify concordance with the
cEEG. A fourth limitation is the uncontrolled setting, which
prevented us from assessing the efficacy of our aggressive
treatment schedule compared to a lower-intensity treatment
schedule. Nonetheless, our main aim was to investigate the
long-term prognosis of RSE compared to other EEG patterns
in a cohort of postanoxic patients treated with a standardized
aggressive treatment. We believe that our findings revealed
some important issues in terms of patient selection and in-
tensity and duration of treatment that could inspire the design
of future randomized controlled trials comparing aggressive
and conservative treatment of postanoxic status epilepticus.
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